Recombinant Viral Capsid Protein L2 (rVL2) of HPV 16 Suppresses Cell Proliferation and Glucose Metabolism via ITGB7/C/EBPβ Signaling Pathway in Cervical Cancer Cell Lines

PURPOSE: Capsid protein L2 is the minor capsid protein of human papillomavirus 16 (HPV16). Although L2-based vaccines were developed, the therapeutic effect of recombinant viral capsid protein L2 (rVL2) was still to be illustrated. METHODS: We used glucose uptake and lactate production assay to veri...

Descripción completa

Detalles Bibliográficos
Autores principales: Chai, Zhihong, Yang, Yufei, Gu, ZhongYi, Cai, Xianli, Ye, Wenwei, Kong, Lin, Qiu, Xiaoxiao, Ying, Lingxiao, Wang, Ziliang, Wang, Linyou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890187/
https://www.ncbi.nlm.nih.gov/pubmed/31819523
http://dx.doi.org/10.2147/OTT.S228631

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890187/
https://www.ncbi.nlm.nih.gov/pubmed/31819523
http://dx.doi.org/10.2147/OTT.S228631

Ejemplares similares